Assessment of time-to-treatment-failure (TTF) as a surrogate endpoint for overall survival (OS) to immune checkpoint inhibitor (ICI) regimens in metastatic renal cell carcinoma (mRCC): Findings from an IMDC analysis. Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Yochum, Zachary
  • Saliby, Renee Maria
  • Xie, Wanling
  • Moritz, Vivien
  • Wells, Connor
  • Ferrier, Evan
  • Zarba, Martin
  • Ebrahimi, Hedyeh
  • Suárez, Cristina
  • Ruiz-Morales, Jose Manuel
  • McKay, Rana R
  • Powles, Thomas
  • Wood, Lori
  • Lalani, Aly-Khan
  • Pal, Sumanta Kumar
  • de Velasco, Guillermo
  • Takemura, Kosuke
  • Agarwal, Neeraj
  • Heng, Daniel Yick Chin
  • Choueiri, Toni K

publication date

  • June 2025